Trial Profile
A study evaluating safety and efficacy of Perampanel in children and adolescents with Lennox–Gastaut Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2018
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Lennox-Gastaut syndrome
- Focus Adverse reactions; Therapeutic Use
- 17 Apr 2018 New trial record